Mitochondrial Protocol
SS-31 (Elamipretide)Complete Dosing & Administration Guide
A revolutionary mitochondria-targeting peptide that works like a direct energy boost for your cells—binding to cardiolipin in your mitochondria to supercharge ATP production, reduce oxidative stress, and protect your cellular powerhouses from age-related decline.
Dose Range
5-40mg
Frequency
Once daily
Route
Subcutaneous injection
Cycle Length
4-6 weeks
Dosing
How much
do I take?
Starting Dose
5-10 mg
Begin with the lower dose to assess your tolerance. SS-31 is rapidly absorbed subcutaneously, typically reaching peak levels within 30-60 minutes. This conservative approach lets you gauge how your body responds before increasing.
Standard Dose
20-40 mg
The 40 mg daily dose has been used in multiple clinical trials and represents the most studied protocol. This is the dosage that showed effects in heart failure and mitochondrial disease studies. Subcutaneous injection is the standard route.
Advanced Dose
40 mg
Extended protocols for those with established tolerance under medical supervision. Some clinical trials have used 40 mg daily for 24+ weeks in specific patient populations. Do not exceed 40 mg daily—higher doses haven't shown additional benefits.
Timing
Best time to take
Morning injection is often preferred since SS-31 supports cellular energy production—aligning with your active hours makes sense. However, timing is flexible based on your schedule.
With food?
SS-31 can be taken regardless of food timing. The peptide is absorbed efficiently whether you've eaten or not, so fit it into whatever routine works best for you.
If stacking
If combining with other peptides, inject at different sites. SS-31 pairs well with NAD+ precursors like NMN for comprehensive mitochondrial support. Space different peptide injections at least 30 minutes apart.
Adjusting Your Dose
Increase if
- +You've completed 2+ weeks at starting dose with no issues
- +You're following a research protocol calling for standard doses
- +Your healthcare provider recommends advancement based on your goals
Decrease if
- -You experience persistent injection site reactions beyond 48 hours
- -Headaches or nausea don't improve after the first week
- -Any unexpected or uncomfortable side effects arise
- -You have any kidney function concerns
Signs of right dose
- ✓Improved energy levels, especially sustained throughout the day
- ✓Better exercise tolerance or recovery
- ✓No significant injection site issues
- ✓General sense of vitality maintained or enhanced
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Administration
How do I
use it?
Reconstitution
What you need
- •Bacteriostatic water (BAC water) for multi-use reconstitution
- •Insulin syringes (29-31 gauge) for accurate dosing
- •Alcohol swabs for cleaning vial tops and injection sites
- •Your SS-31 lyophilized powder vial
Injection
Route
Subcutaneous injection (just under the skin)—the standard method used in clinical trials with approximately 92% bioavailability
Best sites
- •Abdominal area (about 2 inches away from the belly button)
- •Front or outer thigh (middle section)
- •Back of the upper arm
Technique
- 1.Wash your hands thoroughly with soap and water
- 2.Clean the injection site with an alcohol swab and let it air dry completely
- 3.Pinch about an inch of skin to create a fold of fatty tissue
- 4.Insert the needle at a 45-90 degree angle (45 if lean, 90 if you have more subcutaneous tissue)
- 5.Inject the solution slowly and steadily
- 6.Wait 5-10 seconds before withdrawing the needle
- 7.Apply light pressure with a clean swab if needed—do not rub
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
SS-31 (elamipretide) has demonstrated a favorable safety profile across multiple clinical trials, including studies lasting up to 24 weeks. The most common adverse events are mild injection site reactions. In September 2025, elamipretide received FDA approval for Barth syndrome, validating its safety in that population. Most side effects are mild to moderate and typically resolve with continued use or dose adjustment.
Safety data comes from Phase 1-3 clinical trials in various populations including heart failure patients, those with primary mitochondrial myopathies, and Barth syndrome patients. While generally well-tolerated, long-term safety beyond 6 months requires more data in healthy populations. Always work with a healthcare provider when using this compound.
Common Side Effects
Experienced by some users
Injection site reactions
Redness, swelling, itching, or mild pain at the injection site is the most frequently reported side effect in clinical trials. This is your skin's normal reaction to the injection process.
Management: Rotate injection sites between abdomen, thigh, and arm. A cool compress can help reduce discomfort. Reactions typically fade within 24-48 hours.
Headache
Some users experience mild to moderate headaches, particularly during the first week of use. This may be related to changes in cellular energy metabolism.
Management: Stay well-hydrated and consider over-the-counter pain relief if needed. Headaches usually resolve as your body adjusts within the first 1-2 weeks.
Fatigue
Paradoxically, some people feel tired initially even though SS-31 supports energy production. Your body may be recalibrating its energy systems.
Management: Rest as needed and ensure adequate sleep. This typically improves after the first week as mitochondrial function optimizes.
Nausea
Mild stomach upset or nausea can occur, particularly when starting treatment or at higher doses.
Management: Taking your injection with a small meal may help. If persistent, consider temporarily reducing your dose.
Less Common
- •Dizziness
- •Flushing
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Any signs of allergic reaction—stop immediately and seek medical attention
- ×Injection site reactions that spread, worsen, or show signs of infection
- ×Persistent nausea, headaches, or dizziness that don't improve after 2 weeks
- ×Development of kidney-related symptoms (significant changes in urination, swelling)
- ×Any side effect that feels serious or significantly impacts your quality of life
- ×Your healthcare provider advises discontinuation
SS-31 (elamipretide) is FDA-approved only for Barth syndrome. For other uses, it remains a research compound. Never start, stop, or adjust your protocol without guidance from a qualified healthcare provider. This information is for educational purposes only and is not medical advice.
Interactions
With other peptides
- ✓Potentially synergistic pairing—Epithalon targets telomeres while SS-31 targets mitochondria, addressing two major aging mechanisms simultaneously.
- ✓Can be combined for comprehensive cellular protection and healing support. Inject at different sites.
- ✓Both target mitochondrial function through different mechanisms. May have additive effects but combined use hasn't been extensively studied.
- ✓Safe combination for multi-pathway anti-aging approach. Different mechanisms of action without known interactions.
With medications
- !Nephrotoxic drugs (aminoglycosides, NSAIDs) - SS-31 is excreted by the kidneys. Combining with kidney-stressing medications may increase risk of renal issues. Consult your doctor.
- ✓Diabetes medications (metformin, insulin) - Both may affect mitochondrial function or glucose metabolism. Monitor blood sugar more closely during SS-31 use.
- ✓Blood thinners (warfarin, aspirin) - May increase bruising at injection sites. Not dangerous but worth monitoring. Inform your healthcare provider.
- ✓Heart failure medications - SS-31 has been studied in heart failure patients alongside standard medications. Generally compatible but always inform your cardiologist.
With supplements
- ✓CoQ10 (Ubiquinol) - Excellent synergy—both support mitochondrial electron transport chain function through complementary mechanisms.
- ✓NAD+ precursors (NMN, NR) - Potentially beneficial combination for comprehensive mitochondrial support. NMN supports NAD+ levels while SS-31 protects mitochondrial structure.
- ✓PQQ - May work synergistically to support mitochondrial biogenesis and function. Both target different aspects of mitochondrial health.
- ✓Alpha-lipoic acid - Both have antioxidant properties. Safe combination that may provide enhanced mitochondrial protection.
- ✓High-dose iron supplements - Iron can catalyze oxidative reactions in mitochondria. Avoid taking high-dose iron supplements simultaneously—space them out.
Want the Full Picture?
View the complete SS-31 (Elamipretide) research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.
View Full SS-31 (Elamipretide) Profile